Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
HWU, PATRICK
One or more keywords matched the following items that are connected to HWU, PATRICK
Item TypeName
Academic Article Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy.
Academic Article Treating cancer by targeting the immune system.
Academic Article Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2.
Academic Article HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes.
Academic Article Loss of IFN-? Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.
Academic Article Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
Academic Article Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.
Academic Article A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.
Academic Article Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control.
Academic Article Adjuvant Ipilimumab in High-Risk Uveal Melanoma.
Academic Article Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Concept Ipilimumab
Academic Article Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy.
Academic Article Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study.
Academic Article Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma.
Academic Article Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males.
Search Criteria
  • Ipilimumab